Add Yahoo as a preferred source to see more of our stories on Google. Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 ...

Ty Pennington is a paid spokesperson for Insmed. You may know Ty Pennington as “America’s favorite carpenter.” The host of a ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...

The American College of Chest Physicians (CHEST) has released a new clinical guideline on the management of adult bronchiectasis. Published in the journal CHEST, the guideline contains 13 ...

If you have non-cystic fibrosis bronchiectasis, you’re likely an expert on the “lung side” of the disease — the stubborn mucus, the nagging cough, and the constant threat of a flare-up. But by causing ...

BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...

Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...

When youre living with bronchiectasis, your primary goal in managing the condition is to reduce exacerbations episodes in which youre coughing, breathless, and making more phlegm and to prevent the ...

Panelists discuss how emerging DPP1 inhibitor therapies target neutrophil serine proteases to reduce neutrophilic inflammation and neutrophil extracellular trap formation in bronchiectasis. DPP1 ...

Bronchiectasis is a chronic condition of the respiratory system that is due to abnormal widening of the airways as a consequence of an initial damaging factor. The bronchi, located between the trachea ...

For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration has approved Insmed's daily pill brensocatib, which will be sold under the brand name ...